|
Index of reports
> Cases resulting in life threatening events (36)
> Cases with Cardiac Arrest (5)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in life threatening events where reactions include cardiac arrest.
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-20
Patient: female, weighing 7.0 kg (15.4 pounds)
Adverse reactions / side effects: Bradycardia, Cardiac Arrest
Adverse event resulted in: life threatening event
Suspect drug(s):
Aetoxisclerol
Dosage: text:tdd:2 df
Indication: Varices Oesophageal
Aldactone
Indication: Varices Oesophageal
Other drugs received by patient: Propranolol Hydrochloride; Omeprazole; Targocid
Adverse event in 67 year old male receiving Aldactone (Spironolactone)
Reported by a pharmacist from Spain on 2007-04-04
Patient: 67 year old male
Adverse reactions / side effects: Hyperkalaemia, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Sintrom; Digoxin; Cardura; Coropres; Metformin HCL
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Japan on 2007-02-23
Patient: female, weighing 55.3 kg (121.7 pounds)
Adverse reactions / side effects: Metabolic Acidosis, Hyperkalaemia, Hypoglycaemia, Cardiac Arrest, Electromechanical Dissociation, Haemodialysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:25mg
Administration route: Oral
Indication: Diabetic Nephropathy
Blopress
Administration route: Oral
End date: 2006-09-01
Other drugs received by patient: Amaryl; Aspirin; Alfarol; Calcium Lactate; Euglucon; Basen; Melbin; Humulin R
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Japan on 2007-02-13
Patient: female, weighing 55.3 kg (121.7 pounds)
Adverse reactions / side effects: Metabolic Acidosis, Hyperkalaemia, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:25mg
Administration route: Oral
Indication: Diabetic Nephropathy
Blopress
Administration route: Oral
End date: 2006-09-01
Other drugs received by patient: Amaryl; Aspirin; Alfarol; Calcium Lactate
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a individual with unspecified qualification from Japan on 2007-01-30
Patient: female, weighing 55.3 kg (121.7 pounds)
Adverse reactions / side effects: Metabolic Acidosis, Hyperkalaemia, Cardiac Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Aldactone
Dosage: daily dose:25mg
Administration route: Oral
Indication: Diabetic Nephropathy
Blopress
Administration route: Oral
End date: 2006-09-01
Other drugs received by patient: Amaryl; Aspirin; Alfarol; Calcium Lactate
|
